Literature DB >> 31512807

Evaluation of oncologic outcomes in head and neck cancer patients ≥80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment.

Dylan Roden1, Kelly Daniels1, James Metkus1, Richard Goldman1, Amanda Walsh1, Jennifer Johnson2, James Hamilton1, William Keane1, Andrew Chapman2, Voichita Bar-Ad3, Larissa Sweeny4, Joseph Curry1, David Cognetti1, Adam Luginbuhl1.   

Abstract

BACKGROUND: There is a paucity of literature characterizing outcomes in older adult patients with head and neck cancer (HNC). This study aims to describe patients from this group, their adherence to National Comprehensive Cancer Network (NCCN) adjuvant treatment guidelines, and the impact of guideline adherence on overall survival (OS).
METHODS: In this retrospective cohort study, we reviewed all patients ≥80 years old with HNC who underwent surgery with curative intent from 2008 to 2016. Adherence to NCCN guidelines was determined in blinded fashion, and quality metrics and OS were compared.
RESULTS: One hundred fifty-nine patients met inclusion criteria. The majority of patients (n = 94, 59%) underwent treatment in accordance with NCCN recommendations while 65 (41%) deviated from NCCN guidelines. The two cohorts did not demonstrate a difference in 2-year OS (62% vs 66%, P = .50).
CONCLUSION: Older adult patient outcomes were not different when treatment deviated from NCCN guidelines.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  NCCN guidelines; elderly; head and neck cancer; older adults

Mesh:

Year:  2019        PMID: 31512807     DOI: 10.1002/hed.25950

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

1.  Impact of adjuvant radiation therapy after definitive surgery in senior adults >80 years old with advanced head and neck squamous cell carcinoma on overall survival.

Authors:  Joann M Butkus; Meghan Crippen; Voichita Bar-Ad; Adam Luginbuhl
Journal:  Front Oncol       Date:  2022-09-30       Impact factor: 5.738

2.  The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.

Authors:  Jason Tasoulas; Nicholas R Lenze; Douglas Farquhar; Travis P Schrank; Colette Shen; M Ali Shazib; Bart Singer; Shetal Patel; Juneko E Grilley Olson; David N Hayes; Margaret L Gulley; Bhishamjit S Chera; Trevor Hackman; Andrew F Olshan; Jared Weiss; Siddharth Sheth
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

3.  Predictors for Adherence to Treatment Strategies in Elderly HNSCC Patients.

Authors:  Raphaela Graessle; Carmen Stromberger; Max Heiland; Christian Doll; Veit M Hofmann; Konrad Klinghammer; Ingeborg Tinhofer; Heidi Olze; Marcus Beck; Philipp Arens; Steffen Dommerich; Iris Piwonski; Annekatrin Coordes
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.